Tag: anti-inflammatory therapeutics market forecast

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Expected Total Market Size Of The Anti-Inflammatory Therapeutics Industry By The Forecast Year 2029?

The anti-inflammatory therapeutics market has seen consistent expansion in recent years. It is anticipated to increase from $114.71 billion in 2024 to $117.28 billion in 2025, achieving a compound annual growth rate (CAGR) of 2.2%. The historical growth of this market can be linked to the widespread occurrence of chronic illnesses, an aging global population, heightened public awareness, and supportive government initiatives.

The anti-inflammatory therapeutics market is projected to experience consistent expansion over the upcoming years, with its size anticipated to reach $142.15 billion by 2029, driven by a compound annual growth rate (CAGR) of 4.9%. This growth throughout the forecast period can be attributed to the emergence of innovative therapies, increasing healthcare expenditure, a heightened focus on rare diseases, and the development of biologics and biosimilars. Significant trends expected during this period include advancements in immunotherapy, the integration of artificial intelligence (AI) and machine learning (ML) into drug discovery, and the expansion of therapeutic indications.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12861&type=smp

What Are The Main Drivers Boosting The Anti-Inflammatory Therapeutics Industry’s Expansion?

The expanding prevalence of inflammatory bowel disease is projected to boost the future growth of the anti-inflammatory therapeutics market. Inflammatory bowel disease (IBD) is a long-term condition that causes inflammation in the gastrointestinal tract. Anti-inflammatory therapeutics are essential in treating Crohn’s disease by decreasing inflammation, alleviating symptoms, and lessening the need for surgery. As an illustration, in July 2023, Oxford University Press (OUP), the academic publisher of the University of Oxford, reported that the incidence of inflammatory bowel disease (IBD) was 10.9 per 100,000 person-years, and the prevalence stood at 721 per 100,000 people. This rise in inflammatory bowel disease prevalence is, therefore, a key driver for the growth of the anti-inflammatory therapeutics market.

How Is The Anti-Inflammatory Therapeutics Market Segmented?

The anti-inflammatory therapeutics market covered in this report is segmented –

1) By Drug Class: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Anti-Inflammatory Biologics

2) By Indication: Arthritis, Respiratory Diseases, Multiple Sclerosis, Psoriasis, Inflammatory Bowel Diseases, Other Inflammatory Diseases

3) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Distribution

Subsegments:

1) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Ibuprofen, Aspirin, Naproxen, Diclofenac, Celecoxib, Indomethacin, Ketoprofen

2) By Corticosteroids: Prednisone, Dexamethasone, Hydrocortisone, Methylprednisolone, Triamcinolone, Betamethasone

3) By Anti-Inflammatory Biologics: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin Inhibitors, Janus Kinase (JAK) Inhibitors, Monoclonal Antibodies, Recombinant Proteins, Fusion Proteins

What Are The Major Trends Driving The Growth Of The Anti-Inflammatory Therapeutics Market?

Key players within the anti-inflammatory therapeutics market are rolling out innovative drugs to bolster their market standing. For example, in February 2023, Regeneron Pharmaceuticals Inc., a US-based biotechnology company, in collaboration with Sanofi, a France-based pharmaceutical and healthcare company, unveiled Kevzara (sarilumab). This product is notable as the first and only anti-inflammatory biologic recommended for adult patients diagnosed with polymyalgia rheumatic (PMR), an inflammatory rheumatic condition, particularly those who do not adequately respond to corticosteroids or are unable to endure corticosteroid tapering.

Which Global Market Leaders Are Shaping The Future Of The Anti-Inflammatory Therapeutics Sector?

Major companies operating in the anti-inflammatory therapeutics market are Pfizer Inc., Johnson and Johnson Limited, F. Hoffmann-La Roche Ltd., Merck and Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi-Aventis LLC., Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline plc., Takeda Pharmaceutical Company Limited, Eli Lilly and Co Ltd., Amgen Inc., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Biogen Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Sun Pharmaceutical Industries Limited, Otsuka Pharmaceutical Co. Ltd., Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Cipla Inc., Zydus Lifesciences Ltd., Lupin Limited, Torrent Pharmaceuticals Ltd.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/anti-inflammatory-therapeutics-global-market-report

Which Region Is Expected To Witness The Fastest Growth In The Anti-Inflammatory Therapeutics Market?

North America was the largest region in the anti-inflammatory therapeutics market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the anti-inflammatory therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request A Customized Version Of The Anti-Inflammatory Therapeutics Market Report:

https://www.thebusinessresearchcompany.com/customise?id=12861&type=smp

Browse Through More Reports Similar to the Global Anti-Inflammatory Therapeutics Market 2025, By The Business Research Company

Inflammatory Bowel Disease Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/inflammatory-bowel-disease-treatment-global-market-report

Non Steroidal Anti Inflammatory Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/non-steroidal-anti-inflammatory-drugs-global-market-report

Cystic Fibrosis Cf Therapeutics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cystic-fibrosis-cf-therapeutics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Will the Anti-Inflammatory Therapeutics Market Evolve in Terms of Growth and Size by 2029?

The growth of the anti-inflammatory therapeutics market has been consistent over the past few years. It is projected to surge from $114.71 billion in 2024 to $117.28 billion in 2025, with a compound annual growth rate (CAGR) of 2.2%. Factors such as the widespread occurrence of chronic diseases, an aging population, heightened awareness, and government policies have contributed to this growth during the historic period.

In the forthcoming years, the market for anti-inflammatory therapeutics is projected to experience a consistent growth. The market is set to expand to “$142.15 billion by 2029, with a compound annual growth rate (CAGR) of 4.9%. Factors contributing to the projected growth during this prediction period include the development of innovative therapies, rise in healthcare expenditure, emphasis on rare diseases, and the introduction of biologics and biosimilars. Upcoming trends within this predicted timeframe encompass advancements in immunotherapies, the application of artificial intelligence (AI) and machine learning (ML) in drug discovery processes, and broadening of indications.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12861&type=smp

What factors are expected to fuel Anti-Inflammatory Therapeutics market growth in the coming years?

The growth of the anti-inflammatory therapeutics market is predicted to be fueled by the rising prevalence of inflammatory bowel disease. Characterized by chronic inflammation of the gastrointestinal tract, inflammatory bowel disease (IBD) is a persistent health condition. In the management of Crohn’s disease, anti-inflammatory therapeutics are significant as they mitigate inflammation, control disease symptoms, and lower the likelihood of surgical intervention. A July 2023 report from the Oxford University Press (OUP), the publication body of the University of Oxford, recorded IBD incidence at 10.9 per 100,000 person-years and prevalence at 721 per 100,000 individuals. Therefore, this rise in inflammatory bowel disease prevalence is triggering the expansion of the anti-inflammatory therapeutics market.

The anti-inflammatory therapeutics market covered in this report is segmented –

1) By Drug Class: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Anti-Inflammatory Biologics

2) By Indication: Arthritis, Respiratory Diseases, Multiple Sclerosis, Psoriasis, Inflammatory Bowel Diseases, Other Inflammatory Diseases

3) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Distribution

Subsegments:

1) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Ibuprofen, Aspirin, Naproxen, Diclofenac, Celecoxib, Indomethacin, Ketoprofen

2) By Corticosteroids: Prednisone, Dexamethasone, Hydrocortisone, Methylprednisolone, Triamcinolone, Betamethasone

3) By Anti-Inflammatory Biologics: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin Inhibitors, Janus Kinase (JAK) Inhibitors, Monoclonal Antibodies, Recombinant Proteins, Fusion Proteins

What Upcoming Trends Are Expected To Impact The Anti-Inflammatory Therapeutics Market Globally?

Key players in the anti-inflammatory therapeutics industry are creating pioneering drugs to fortify their market standing. For example, Regeneron Pharmaceuticals Inc., an American biotech firm, together with Sanofi, a French pharmaceutical and healthcare company, introduced Kevzara (sarilumab) in February 2023. This is the first and only anti-inflammatory biologic recommended for adult patients with PMR, an inflammatory rheumatic disease, who either do not have a proper response to corticosteroids or are unable to tolerate corticosteroid tapering.

What Are The Most Active Companies In The Anti-Inflammatory Therapeutics Market Today?

Major companies operating in the anti-inflammatory therapeutics market are Pfizer Inc., Johnson and Johnson Limited, F. Hoffmann-La Roche Ltd., Merck and Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi-Aventis LLC., Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline plc., Takeda Pharmaceutical Company Limited, Eli Lilly and Co Ltd., Amgen Inc., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Biogen Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Sun Pharmaceutical Industries Limited, Otsuka Pharmaceutical Co. Ltd., Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Cipla Inc., Zydus Lifesciences Ltd., Lupin Limited, Torrent Pharmaceuticals Ltd.

https://www.thebusinessresearchcompany.com/report/anti-inflammatory-therapeutics-global-market-report

Which Regional Markets Are Attracting The Most Investment In Anti-Inflammatory Therapeutics?

North America was the largest region in the anti-inflammatory therapeutics market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the anti-inflammatory therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=12861&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Anti-Inflammatory Therapeutics Market Growth Performance Trended Historically, And What Lies Ahead?

The market size of anti-inflammatory therapeutics has shown consistent growth in the past few years. It is projected to elevate from $114.71 billion in 2024 to $117.28 billion in 2025, witnessing a compound annual growth rate (CAGR) of 2.2%. Factors contributing to growth during the historical period include the widespread occurrence of chronic diseases, an aging population, heightened awareness, and government intervention.

The market size for anti-inflammatory therapeutics is predicted to grow at a steady pace in the upcoming years, reaching a value of $142.15 billion by 2029 with a compound annual growth rate (CAGR) of 4.9%. This anticipated growth during the forecast period is as a result of innovative treatment methods, heightened healthcare spending, emphasis on curing rare illnesses, biologics and biosimilars. Key advancements expected to make a significant impact in this period include progress in immunotherapy, the incorporation of artificial intelligence (AI) and machine learning (ML) in drug discovery, and the broadening of indications.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12861&type=smp

What Are the Primary Drivers Supporting the Market Growth of the Anti-Inflammatory Therapeutics Market?

The escalating incidence of inflammatory bowel disease (IBD) is anticipated to fuel the expansion of the market for anti-inflammatory therapeutics. IBD, a persistent disease, triggers inflammation in the digestive tract. Anti-inflammatory therapeutics are pivotal in treating Crohn’s disease by lessening inflammation, managing the disease’s symptoms, and lowering the risk of surgical intervention. For example, the Oxford University Press (OUP), the university press of the University of Oxford, reported in July 2023 the IBD incidence rate at 10.9 per 100,000 person-years, and a prevalence rate of 721 per 100,000 individuals. Hence, this rising prevalence of IBD is propelling the expansion of the anti-inflammatory therapeutics market.

Which Primary Segments of the Anti-Inflammatory Therapeutics Market Are Driving Growth and Industry Transformations?

The anti-inflammatory therapeutics market covered in this report is segmented –

1) By Drug Class: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Anti-Inflammatory Biologics

2) By Indication: Arthritis, Respiratory Diseases, Multiple Sclerosis, Psoriasis, Inflammatory Bowel Diseases, Other Inflammatory Diseases

3) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Distribution

Subsegments:

1) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Ibuprofen, Aspirin, Naproxen, Diclofenac, Celecoxib, Indomethacin, Ketoprofen

2) By Corticosteroids: Prednisone, Dexamethasone, Hydrocortisone, Methylprednisolone, Triamcinolone, Betamethasone

3) By Anti-Inflammatory Biologics: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin Inhibitors, Janus Kinase (JAK) Inhibitors, Monoclonal Antibodies, Recombinant Proteins, Fusion Proteins

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=12861&type=smp

Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of the Anti-Inflammatory Therapeutics Market?# Market?

North America was the largest region in the anti-inflammatory therapeutics market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the anti-inflammatory therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

What Are the Most Significant Market Trends in the Anti-Inflammatory Therapeutics Market?

Leading firms in the anti-inflammatory therapeutics market are innovating and launching new drugs to reinforce their market presence. As an example, in February 2023, Regeneron Pharmaceuticals Inc. from the U.S., a firm specializing in biotechnology, along with France-based pharmaceutical and healthcare company Sanofi, introduced a new drug named Kevzara (sarilumab). This drug is unique as it’s the only anti-inflammatory biologic recommended for adult patients suffering from polymyalgia rheumatic (PMR), a type of inflammatory rheumatic disorder. It is specifically suggested for those patients who do not show adequate response to corticosteroids or those who cannot tolerate corticosteroid tapering.

View the full report here:

https://www.thebusinessresearchcompany.com/report/anti-inflammatory-therapeutics-global-market-report

What Parameters Are Used to Define the Anti-Inflammatory Therapeutics Market?

Anti-inflammatory therapeutics refer to prescription medications that treat pain, lessen inflammation, and lower a high body temperature. It acts as a host response modifier and plays a crucial role in managing acute and chronic headaches, painful phases, sprains, and strain problems.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12861

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Anti-Inflammatory Therapeutics Market from 2024 to 2025?

In recent times, there has been consistent growth in the market size of anti-inflammatory therapeutics. It is projected to increase from $114.71 billion in 2024 to $118.44 billion in 2025, indicating a compound annual growth rate (CAGR) of 3.3%. Factors that have contributed to the growth during the historic period include the rise of chronic diseases, an aging population, heightened awareness, and government initiatives.

What Is the Projected Market Size of the Anti-Inflammatory Therapeutics Market?

Projected to see substantial growth in the coming years, the anti-inflammatory therapeutics market is estimated to reach $144.05 billion in 2029, growing at a compounded annual growth rate of 5.0%. This anticipated growth within the forecast period is largely due to innovative treatments, heightened healthcare spending, emphasis on rare diseases, and the development of biologics and biosimilars. Key trends expected to influence the forecast period include progresses in immunotherapy, the application of artificial intelligence (AI) and machine learning (ML) in pharmaceutical discovery, and an extended range of indications.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12861&type=smp

Who are the Major Competitors in the Anti-Inflammatory Therapeutics Market Outlook?

Major companies operating in the anti-inflammatory therapeutics market are Pfizer Inc., Johnson and Johnson Limited, F. Hoffmann-La Roche Ltd., Merck and Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi-Aventis LLC., Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline plc., Takeda Pharmaceutical Company Limited, Eli Lilly and Co Ltd., Amgen Inc., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Biogen Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Sun Pharmaceutical Industries Limited, Otsuka Pharmaceutical Co. Ltd., Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Cipla Inc., Zydus Lifesciences Ltd., Lupin Limited, Torrent Pharmaceuticals Ltd.

What Is Fueling Growth in the Anti-Inflammatory Therapeutics Market?

The growth of the anti-inflammatory therapeutics market is likely to be fuelled by the rising incidence of inflammatory bowel disease. Gastrointestinal inflammation, a characteristic of this chronic ailment, is effectively treated with anti-inflammatory therapeutics. They aid in managing the disease’s symptoms, lessening inflammation, and mitigating the chance of surgery. According to the Oxford University Press in July 2023, inflammatory bowel disease has a prevalence rate of 721 per 100,000 individuals and incidences are at a rate of 10.9 per 100,000 person-years. This escalating occurrence of inflammatory bowel disease propels the growth of the anti-inflammatory therapeutics market. With an anticipated surge in autoimmune disorder incidences, there is an expected robust growth in the anti-inflammatory therapeutics market. Autoimmune disorders, a medical condition that mistakenly activates the immune system to launch an attack on the body’s healthy cells, have been on the rise. Anti-inflammatory therapeutics are critical in the management of these disorders, where they work to curtail inflammation, control the exaggerated reaction of the immune system, and alleviate symptoms associated with these disorders. As projected by the Guardian Media Group in January 2022, autoimmune disorders will affect 4 million individuals in the UK and globally the rates are are expected to increase annually by 3% to 9%. Furthermore, Oxford University reported in May 2023, that 10% of the global population is affected by autoimmune disorders. This surge in autoimmune disorders bolsters the growth of the anti-inflammatory therapeutics market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=12861&type=smp

Which Anti-Inflammatory Therapeutics Market Segments Are Growing the Fastest?

The anti-inflammatory therapeutics market covered in this report is segmented –

1) By Drug Class: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Anti-Inflammatory Biologics

2) By Indication: Arthritis, Respiratory Diseases, Multiple Sclerosis, Psoriasis, Inflammatory Bowel Diseases, Other Inflammatory Diseases

3) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Distribution

Subsegments:

1) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Ibuprofen, Aspirin, Naproxen, Diclofenac, Celecoxib, Indomethacin, Ketoprofen

2) By Corticosteroids: Prednisone, Dexamethasone, Hydrocortisone, Methylprednisolone, Triamcinolone, Betamethasone

3) By Anti-Inflammatory Biologics: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin Inhibitors, Janus Kinase (JAK) Inhibitors, Monoclonal Antibodies, Recombinant Proteins, Fusion Proteins

Which Industry Trends Are Shaping the Future of the Anti-Inflammatory Therapeutics Market?

Leading businesses in the anti-inflammatory therapeutics market are debuting groundbreaking drugs to fortify their market presence. For example, in February 2023, US-based biotech firm Regeneron Pharmaceuticals Inc., together with Sanofi, a pharmaceutical and healthcare firm from France, unveiled Kevzara (sarilumab). This is the first and sole anti-inflammatory biologic suggested for adult patients suffering from polymyalgia rheumatic (PMR), an inflammatory rheumatic disorder, which fails to respond adequately to corticosteroids or whose tolerance to corticosteroid tapering is low.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/anti-inflammatory-therapeutics-global-market-report

Which Countries Are Leading the Anti-Inflammatory Therapeutics Market?

North America was the largest region in the anti-inflammatory therapeutics market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the anti-inflammatory therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12861

This Report Delivers Insight On:

1. How big is the anti-inflammatory therapeutics market, and how is it changing globally?

2. Who are the major companies in the anti-inflammatory therapeutics market, and how are they performing?

3. What are the key opportunities and risks in the anti-inflammatory therapeutics market right now?

4. Which products or customer segments are growing the most in the anti-inflammatory therapeutics market?

5. What factors are helping or slowing down the growth of the anti-inflammatory therapeutics market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the anti-inflammatory therapeutics industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

How Fast Is The Anti-Inflammatory Therapeutics Market Expected to Grow Between 2025 And 2029?

In the past years, the size of the anti-inflammatory therapeutics market has continually increased. It’s forecasted to expand from $114.71 billion in 2024 to $118.44 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 3.3%. Factors contributing to this growth during the historical period include the surge in chronic diseases, an aging population, higher levels of awareness, and government efforts.

Predictions show a robust expansion in the anti-inflammatory therapeutics market in the coming years. The market is anticipated to reach a size of $144.05 billion by 2029, with a compound annual growth rate (CAGR) of 5.0%. Key drivers for this prospective growth during the forecast period include innovative treatments, heightened healthcare spending, attention to rare diseases, and the development of biologics and biosimilars. Trending advancements in the same period are expected to include progress in immunotherapy, the application of artificial intelligence (AI) and machine learning (ML) in medicinal discovery, and an increase in indications.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12861&type=smp

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Anti-Inflammatory Therapeutics Market?

The escalating incidence of inflammatory bowel disease is anticipated to boost the expansion of the anti-inflammatory therapeutics market. As a long-term ailment that leads to the inflammation of the gastrointestinal tract, inflammatory bowel disease (IBD) is significantly managed with the aid of anti-inflammatory therapeutics. These therapeutics are instrumental in mitigating inflammation, handling the symptoms, and reducing the probability of surgery in patients with Crohn’s disease. For instance, Oxford University Press (OUP), which is the university press for the University of Oxford, reported in July 2023 that the incidence rate of inflammatory bowel disease (IBD) is 10.9 per 100,000 person-years, and the prevalence rate is 721 per 100,000 individuals. Hence, the escalating incidence of inflammatory bowel disease significantly contributes to the growth of the anti-inflammatory therapeutics market. The Anti-Inflammatory Therapeutics Market is greatly influenced by the prevalence of Autoimmune Disorder, and the surge in this prevalence is predicted to foster robust growth in the same market. The continuous rise in the frequency of autoimmune disorders is also predicted to strongly boost the expansion of the anti-inflammatory therapeutics market. Autoimmune disorders refer to a series of health conditions where the immune system wrongly targets and attacks the body’s own healthy cells and tissues instead of harmful invaders such as bacteria and viruses. The continuous rise of autoimmune disorders significantly impacts the growth of anti-inflammatory therapeutics. Such therapeutics are widely used in treating autoimmune disorders by aiming to lessen inflammation, curb the overactive response of the immune system and ease the symptoms associated with these conditions. For example, reports published by the UK-based Guardian Media Group in January 2022 project that 4 million individuals in the UK will be affected by autoimmune disorders, and it is estimated that this number will increase globally by 3% to 9% every year. Moreover, according to the University of Oxford, another UK-based research university, autoimmune disorders were impacting 10% of the global population by May 2023. Hence, the continuous rise in the frequency of autoimmune disorders significantly contributes to the growth of the anti-inflammatory therapeutics market.

Which Key Market Segments Comprise the Anti-Inflammatory Therapeutics Market and Drive Its Revenue Growth?

The anti-inflammatory therapeutics market covered in this report is segmented –

1) By Drug Class: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Anti-Inflammatory Biologics

2) By Indication: Arthritis, Respiratory Diseases, Multiple Sclerosis, Psoriasis, Inflammatory Bowel Diseases, Other Inflammatory Diseases

3) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Distribution

Subsegments:

1) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Ibuprofen, Aspirin, Naproxen, Diclofenac, Celecoxib, Indomethacin, Ketoprofen

2) By Corticosteroids: Prednisone, Dexamethasone, Hydrocortisone, Methylprednisolone, Triamcinolone, Betamethasone

3) By Anti-Inflammatory Biologics: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin Inhibitors, Janus Kinase (JAK) Inhibitors, Monoclonal Antibodies, Recombinant Proteins, Fusion Proteins

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=12861&type=smp

Which Areas Are Leading Regions in the Anti-Inflammatory Therapeutics Market Expansion Across the Globe?

North America was the largest region in the anti-inflammatory therapeutics market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the anti-inflammatory therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

What Are the Key Market Trends in the Anti-Inflammatory Therapeutics Market Over the Coming Years?

Main businesses in the market for anti-inflammatory treatments are launching novel drugs in an effort to solidify their market standings. As an example, in February 2023, the American biotech entity, Regeneron Pharmaceuticals Inc., and Sanofi, a French pharmaceutical and healthcare enterprise, introduced Kevzara (sarilumab). This is the inaugural and sole anti-inflammatory biologic suggested for matured patients suffering from polymyalgia rheumatic (PMR), an inflammation-related rheumatic condition. It’s specifically catered to those unresponsive to corticosteroids or those who cannot tolerate corticosteroid tapering.

View the full report here:

https://www.thebusinessresearchcompany.com/report/anti-inflammatory-therapeutics-global-market-report

How Is the Anti-Inflammatory Therapeutics Market Conceptually Defined?

Anti-inflammatory therapeutics refer to prescription medications that treat pain, lessen inflammation, and lower a high body temperature. It acts as a host response modifier and plays a crucial role in managing acute and chronic headaches, painful phases, sprains, and strain problems.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12861

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Anti-Inflammatory Therapeutics Market?

The surge in instances of inflammatory bowel disease (IBD) is anticipated to fuel the expansion of the anti-inflammatory therapeutics market. IBD is a long-term condition causing inflammation in the gastrointestinal tract, with anti-inflammatory therapeutics being integral in the treatment of illnesses like Crohn’s disease, aiding in inflammation reduction, symptom management, and lowering surgical risks. For instance, Oxford University Press (OUP), the press of the University of Oxford, reported in July 2023 that the incidence of IBD is 10.9 per 100,000 person-years, and the prevalence is 721 per 100,000 individuals. Consequently, the spike in IBD prevalence is bolstering the anti-inflammatory therapeutics market’s growth.

Anti-Inflammatory Therapeutics Market Driver: Skyrocketing Prevalence of Autoimmune Disorders Anticipated To Power Notable Growth in The Anti-Inflammatory Therapeutics Market

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12861&type=smp

How Has the Anti-Inflammatory Therapeutics Market Evolved in Recent Years, and What are the Growth Projections for the Forecast Period?

Over the past several years, the anti-inflammatory therapeutics market has been witnessing consistent growth. The market is projected to expand from its size of $114.71 billion in 2024 to $118.44 billion in 2025, projecting a compound annual growth rate (CAGR) of 3.3%. Factors such as the rise in chronic diseases, an aging population, enhanced awareness, and government interventions have contributed to the growth during the historical period.

The market for anti-inflammatory therapeutics is projected to witness substantial growth in the coming years, expanding to $144.05 billion in 2029 with a compound annual growth rate (CAGR) of 5.0%. The predicted growth in this period is linked to innovations in therapy, a rise in healthcare spending, attention on rare diseases, and the advent of biologics and biosimilars. Key trends predicted during this forecast period are developments in immunotherapy, the use of artificial intelligence (AI) and machine learning (ML) in drug discovery, and an expansion in indications.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12861

What Are the Key Market Innovations in theAnti-Inflammatory Therapeutics Market Over the Coming Years?

Leading corporations in the anti-inflammatory therapeutics market are releasing novel drugs to consolidate their market standing. Specifically, in February 2023, US biotech company Regeneron Pharmaceuticals Inc., in collaboration with Sanofi, a pharmaceutical and healthcare company based in France, unveiled Kevzara (sarilumab). This is the only anti-inflammatory biologic advised for adults with polymyalgia rheumatic (PMR), a type of inflammatory rheumatic condition. It is especially beneficial for patients who either do not respond satisfactorily to corticosteroids or cannot withstand corticosteroid tapering.

Who Are the Top Companies Driving Innovation and Growth in theAnti-Inflammatory Therapeutics Market?

Major companies operating in the anti-inflammatory therapeutics market are Pfizer Inc., Johnson and Johnson Limited, F. Hoffmann-La Roche Ltd., Merck and Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi-Aventis LLC., Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline plc., Takeda Pharmaceutical Company Limited, Eli Lilly and Co Ltd., Amgen Inc., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Biogen Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Sun Pharmaceutical Industries Limited, Otsuka Pharmaceutical Co. Ltd., Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Cipla Inc., Zydus Lifesciences Ltd., Lupin Limited, Torrent Pharmaceuticals Ltd.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/anti-inflammatory-therapeutics-global-market-report

Which Key Market Segments Comprise the Anti-Inflammatory Therapeutics Market and Drive Its Revenue Growth?

The anti-inflammatory therapeutics market covered in this report is segmented –

1) By Drug Class: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Anti-Inflammatory Biologics

2) By Indication: Arthritis, Respiratory Diseases, Multiple Sclerosis, Psoriasis, Inflammatory Bowel Diseases, Other Inflammatory Diseases

3) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Distribution

Subsegments:

1) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Ibuprofen, Aspirin, Naproxen, Diclofenac, Celecoxib, Indomethacin, Ketoprofen

2) By Corticosteroids: Prednisone, Dexamethasone, Hydrocortisone, Methylprednisolone, Triamcinolone, Betamethasone

3) By Anti-Inflammatory Biologics: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin Inhibitors, Janus Kinase (JAK) Inhibitors, Monoclonal Antibodies, Recombinant Proteins, Fusion Proteins

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=12861&type=smp

Which Regions Are Emerging as Leaders in the Anti-Inflammatory Therapeutics Market?

North America was the largest region in the anti-inflammatory therapeutics market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the anti-inflammatory therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Reports Similar to the Global Anti-Inflammatory Therapeutics Market 2025, By The Business Research Company:

Network Centric Warfare Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/network-centric-warfare-global-market-report

Artificial Intelligence In Modern Warfare Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-modern-warfare-global-market-report

Submarine Combat System Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/submarine-combat-system-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What key factors are powering the surge in the anti-inflammatory therapeutics market right now?

The market size for anti-inflammatory therapeutics has shown consistent growth over the past years. The market is expected to expand from $114.71 billion in 2024 to $118.44 billion in 2025, showcasing a compound annual growth rate (CAGR) of 3.3%. The escalation during the historical period was influenced by factors such as the surge in chronic illnesses, aging demographic, heightened awareness, and government-driven initiatives.

How fast Is the anti-inflammatory therapeutics market expected to grow, and what’s its future value?

The market size of anti-inflammatory therapeutics is predicted to witness considerable expansion in the upcoming years, reaching a figure of $144.05 billion in 2029 with a compound annual growth rate (CAGR) of 5.0%. The anticipated progression in this timeframe can be ascribed to the emergence of innovative therapies, a surge in healthcare spending, attention towards rare diseases, and developments in biologics and biosimilars. Key advancements projected for this period include progress in immunotherapy, the involvement of artificial intelligence (AI) and machine learning (ML) in drug discovery, and the broadening of indications.

Get your anti-inflammatory therapeutics market report here!

https://www.thebusinessresearchcompany.com/report/anti-inflammatory-therapeutics-global-market-report

What are the leading drivers of growth in the anti-inflammatory therapeutics market?

The growth of the anti-inflammatory therapeutics market is likely to be fueled by the escalating prevalence of inflammatory bowel disease. This chronic condition involves inflammation of the gastrointestinal tract, with anti-inflammatory therapeutics proving vital in treating conditions like Crohn’s disease. They help decrease inflammation, control disease symptoms, and lower the need for surgical intervention. The University Press of the University of Oxford reported in July 2023 that the incidence rate of inflammatory bowel disease (IBD) was 10.9 per 100,000 person-years and the prevalence rate was 721 per 100,000 individuals. Such mounting prevalence rates of inflammatory bowel disease (IBD) signpost a growth trajectory for the anti-inflammatory therapeutics market. Anticipated increases in the prevalence of autoimmune disorders also prompts optimism for continued growth in the anti-inflammatory therapeutics market. Autoimmune disorders constitute medical conditions where the immune system erroneously attacks the body’s healthy cells and tissues it is designed to protect against harmful invaders like bacteria and viruses. Treatment for these disorders typically involves anti-inflammatory therapeutics designed to reduce inflammation, regulate the immune system’s hyperactive response, and relieve associated symptoms. For example, the Guardian Media Group predicted in January 2022 that 4 million people in the UK will experience autoimmune disorders, with global rates projected to increase by 3-9% annually. Furthermore, the University of Oxford reported in May 2023 that 10% of the global population is affected by autoimmune disorders. With these statistics in mind, the increasing prevalence of autoimmune disorders is instrumental in propelling the anti-inflammatory therapeutics market’s growth.

What are the key segments defining the anti-inflammatory therapeutics market?

The anti-inflammatory therapeutics market covered in this report is segmented –

1) By Drug Class: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Anti-Inflammatory Biologics

2) By Indication: Arthritis, Respiratory Diseases, Multiple Sclerosis, Psoriasis, Inflammatory Bowel Diseases, Other Inflammatory Diseases

3) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Distribution

Subsegments:

1) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Ibuprofen, Aspirin, Naproxen, Diclofenac, Celecoxib, Indomethacin, Ketoprofen

2) By Corticosteroids: Prednisone, Dexamethasone, Hydrocortisone, Methylprednisolone, Triamcinolone, Betamethasone

3) By Anti-Inflammatory Biologics: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin Inhibitors, Janus Kinase (JAK) Inhibitors, Monoclonal Antibodies, Recombinant Proteins, Fusion Proteins

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12861&type=smp

Who are the key players steering the development of the anti-inflammatory therapeutics market?

Major companies operating in the anti-inflammatory therapeutics market are Pfizer Inc., Johnson and Johnson Limited, F. Hoffmann-La Roche Ltd., Merck and Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi-Aventis LLC., Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline plc., Takeda Pharmaceutical Company Limited, Eli Lilly and Co Ltd., Amgen Inc., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Biogen Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Sun Pharmaceutical Industries Limited, Otsuka Pharmaceutical Co. Ltd., Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Cipla Inc., Zydus Lifesciences Ltd., Lupin Limited, Torrent Pharmaceuticals Ltd.

What emerging trends are influencing the growth of the anti-inflammatory therapeutics market?

The anti-inflammatory therapeutics market is seeing the introduction of novel drugs by leading companies, solidifying their market stance. For example, Regeneron Pharmaceuticals Inc., an American biotechnology corporation, and Sanofi, a French pharmaceutical and healthcare enterprise, deployed Kevzara (sarilumab) in February 2023. This anti-inflammatory biologic, unique in its recommendations, is for adults with polymyalgia rheumatic (PMR), a type of inflammatory rheumatic disease, who have not appropriately responded to corticosteroids or who cannot tolerate corticosteroid tapering.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12861

Which regions are most influential in expanding the anti-inflammatory therapeutics market?

North America was the largest region in the anti-inflammatory therapeutics market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the anti-inflammatory therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Similar Reports By The Business Research Company:

Network Centric Warfare Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/network-centric-warfare-global-market-report

Artificial Intelligence In Modern Warfare Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-modern-warfare-global-market-report

Submarine Combat System Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/submarine-combat-system-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: